ketoconazole has been researched along with Autism Spectrum Disorder in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, S | 1 |
| Ma, M | 1 |
| Zhang, L | 1 |
| Liu, L | 1 |
| Cheng, B | 1 |
| Qi, X | 1 |
| Liang, C | 1 |
| Li, P | 1 |
| Kafle, OP | 1 |
| Wen, Y | 1 |
| Zhang, F | 1 |
1 other study available for ketoconazole and Autism Spectrum Disorder
| Article | Year |
|---|---|
CGSEA: A Flexible Tool for Evaluating the Associations of Chemicals with Complex Diseases.
Topics: Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Crizotinib; Ethoxyquin; Fem | 2020 |